Kits Eyecare, the Consumer Cyclical sector company, was revisited by a Wall Street analyst yesterday. Analyst Gianluca Tucci from Haywood reiterated a Buy rating on the stock and has a C$24.00 price target.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Gianluca Tucci has given his Buy rating due to a combination of factors tied to KITS’ current performance and long‑term positioning. He notes that the company delivered revenue and adjusted EBITDA in line with guidance, with margins helped by a tariff refund and strong momentum in its higher‑growth glasses segment, which now accounts for a growing share of sales.
He also emphasizes that KITS is sustaining more than 20% constant‑currency organic growth, supported by a vertically integrated platform that scales efficiently, with lab capacity far above current revenue and minimal additional capital required. Against the backdrop of a global eyewear market shifting rapidly online, Tucci views recent share price weakness as a chance to accumulate a leading digital disruptor, even as he trims his price target from $27 to $24.
In another report released on April 28, Roth MKM also maintained a Buy rating on the stock with a C$26.00 price target.